title: Percutaneous closure of patent ductus arteriosus: a multiinstitutional registry comparing multiple devices.
abstract: BACKGROUND
  There are no guidelines and multiple devices available now for closure of PDA.
  
  
  OBJECTIVE
  We sought to determine which devices are used and their outcomes.
  
  
  METHODS
  Prospectively collected data on closure of PDA at 12 US catheterization labs was entered into the MAGIC data registry between November 2005 and September 2008.
  
  
  RESULTS
  PDA closure was accomplished in 357 of 359 attempted closures during the study period. Mean age, weight, and minimum ductal diameter were 4.3 ± 6.8 years, 18.7 ± 18.4 kg, and 2.1 ± 1.4 mm, respectively. Devices used were Gianturco coils (161/359), Amplatzer Duct Occluder (ADO, 174/359), Flipper coils (18/359), and other devices (6/359). Gianturco coils had the least fluoroscopy and contrast exposure (8.7 ± 7.5 min, P = 0.00001, 2.6 ± 1.4 cm(3) kg(-1), P = 0.00001). Immediate angiographic success rates were 96.9% (156/161) for Gianturco coils, 89.7% (156/174) for the ADO, 100% (18/18) for Flipper coils, and 66.7% (4/6) for other devices. Major complication rates were 0.6% for Gianturco coils (1/161), 1.7% for ADO (3/174), and 83.3% for other devices (4/6). Minor complication rates by device were 1.9% for Gianturco coils (3/161), 2.3% for ADO (4/174), and 16.7% (1/6) for other devices.
  
  
  CONCLUSIONS
  Gianturco coils, the ADO and Flipper coils were immediately successful with low complication profiles. The ADO and Gianturco coils were the predominate devices. The ADO was the device of choice for PDA > 3 mm with good success. In PDA < 3 mm, the Gianturco coil is as effective and safe as the ADO with less cost, less radiation, and less contrast exposure. © 2010 Wiley-Liss, Inc.
authors.affiliation: Department of Anesthesiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
authors.forename: Marissa A
authors.initials: MA
authors.lastname: Brunetti
authors.forename: Richard
authors.initials: R
authors.lastname: Ringel
authors.forename: Carl
authors.initials: C
authors.lastname: Owada
authors.forename: John
authors.initials: J
authors.lastname: Coulson
authors.forename: Jacky M
authors.initials: JM
authors.lastname: Jennings
authors.forename: Mark H
authors.initials: MH
authors.lastname: Hoyer
authors.forename: Allen D
authors.initials: AD
authors.lastname: Everett
mesh_terms: D000293:Adolescent; D000328:Adult; D006328:Cardiac Catheterization / Q000009:adverse effects / Q000295:instrumentation*; D002648:Child; D002675:Child, Preschool; D004374:Ductus Arteriosus, Patent / Q000000981:diagnostic imaging / Q000628:therapy*; D006801:Humans; D007223:Infant; D008875:Middle Aged; D018579:Patient Selection; D011446:Prospective Studies; D011474:Prosthesis Design; D011829:Radiation Dosage; D015641:Radiography, Interventional; D012042:Registries; D018570:Risk Assessment; D012307:Risk Factors; D055989:Septal Occluder Device; D013997:Time Factors; D016896:Treatment Outcome; D014481:United States; D055815:Young Adult